View Clinical Trial (Medical Research Study)

Randomized Controlled Clinical Trial of Weight Loss Programs in Obese Persons - NCT00960414-94115(Clinical Trial 306080)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  San Francisco
State:  
CA
Zip Code: 94115
Conditions: Obesity
Purpose: The purpose of this study is to compare two approaches to a diet and exercise-based weight loss program.
Study summary: The high prevalence of obesity and its medical consequences make it one of the most important public health issues in the United States today. Few interventions have been consistently successful at reducing obesity. This trial will test an intervention program that lasts 22 weeks, with 16 evening sessions and one weekend day. Participants will be randomized to one of two arms. Both arms will receive diet and exercise intervention elements. The study aims for gradual weight loss, with a calorie target that will maintain ideal body weight, rather than a more calorie restricted diet. The exercise component is based around increasing walking. The arms will compare methods for producing long-lasting behavior change.
Criteria: Inclusion Criteria: - Age 18+ years old - BMI > 30-45 - Waist circumference > 102 cm (men) or > 88 cm (women) - Live in San Francisco Bay Area and able to attend more than 16 classes and up to 12 assessment visits in San Francisco over an 18 month period Exclusion Criteria: - Inability to provide informed consent - Age < 18 - A substance abuse, mental health, or medical condition that, in the opinion of investigators, will make it difficult for the potential participant to participate in the group intervention - Type I or II Diabetes or fasting glucose ≥ 126 mg/dl or hemoglobin A1c ≥ 6 - Use of systemic (oral or IV) corticosteroids in the 6 months prior to enrollment or severe autoimmune disorders or other conditions (e.g. rheumatoid arthritis, lupus), that are likely to require these medications - Use of immunosuppressive or immunomodulating drugs or chronic or acute conditions that would require the use of such medications - A history of known coronary artery disease (CAD), or typical or atypical anginal chest pain requires a letter from the participant's physician that he or she has been adequately evaluated and that a moderate exercise program is appropriate - Non English speaker - Pregnant or planning to get pregnant in the next 12 months, breastfeeding or less than 6 months post-partum - Initiation of new class of psychiatric medications in past 2 months - Currently on a specific weight loss diet - For influenza vaccine administration: a prior allergic reaction to the influenza vaccine or eggs. These participants can be included in the trial but will be excluded from participation in influenza vaccination. - Active bulimia or strong history of bulimia - Current use of weight loss medications or supplements such as amphetamine-based drugs that are believed to have some effect on weight - History of or planned weight loss surgery - Untreated hypothyroidism: TSH > 4mU/mL (or the upper limit of normal reference defined by the lab doing the assay)
Study is available at: Osher Center for Integrative Medicine
San Francisco, CA 94115
United States

Primary Contact:
Patricia Moran, PhD
Email: moranp@ocim.ucsf.edu
Phone: 415-353-9745
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 23, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.